Home/IPOs/FabtechTechnologies
F

FabtechTechnologies IPO

Fabtech Technologies
Start Date29-09-2025
Application Timing10am-5pm
Price Range₹181 - ₹191
Min Qty75
Min. Investment₹14325
Listing Date07-10-2025
Close Date01-09-2025

About Fabtech Technologies

Fabtech Technologies Ltd, incorporated in 2018, is a biopharma engineering company that specializes in turnkey projects and integrated engineering solutions. The company provides end-to-end services such as design, engineering, manufacturing, installation, and project management.

Fabtech is well-known for its expertise in cleanroom technology, HVAC systems, and process equipment, catering to global clients across life sciences, food & beverages, IT, semiconductors, and aeronautics industries. Its offerings include clean water solutions, clean air systems, modular facilities, and project execution with compliance to international standards.

As of July 31, 2025, the company had 185 permanent employees.

Why To Invest in Fabtech Technologies

Strong Financial Growth: Revenue grew by 46% and PAT increased by 71% in FY25 compared to FY24.

Healthy Margins: The company reported EBITDA margin of 14.07% and PAT margin of 13.83% in FY25.

Scalable Business Model: Fabtech serves diverse sectors like pharma, food, IT, and aerospace, reducing sector-specific risks.

Global Presence: Proven ability to execute projects across challenging geographies.

Robust Order Book: Diversified client base and strong track record in handling multiple dosage forms.

Experienced Leadership: Backed by the Fabtech Group with a seasoned management team.

Financial Table
Period Ended 31 Mar 2025 31 Mar 2024 31 Mar 2023
Assets426.56 269.24213.86
Total Income335.94230.39199.91
Profit After Tax46.4527.2221.73
EBITDA47.2840.6934.86
NET Worth173.11131.8888.96
Reserves and Surplus140.72128.9486.18
Total Borrowing54.629.8834.29
Strengths And Risks
+
Leading Turnkey Biopharma Engineering Provider: Fabtech Technologies has established itself as a key turnkey solution provider in the biopharma engineering space, offering comprehensive services from design to execution.
+
Strong In-house Technology Capabilities: The company has in-house software and engineering expertise, which enhances efficiency and reduces dependency on external resources.
+
Diversified Order Book: Fabtech serves multiple industries and geographies, ensuring a well-balanced and risk-mitigated order book across clients and verticals.
+
Efficient Project Execution: With proven expertise in executing projects across challenging environments, the company has developed strong mandate conversion capabilities.
+
Consistent Financial Growth: The company has shown steady growth with robust financial metrics, including a Return on Equity (ROE) of 30.46% and Return on Capital Employed (ROCE) of 24.46%.
-
Sector Dependency: A large portion of Fabtech’s business is concentrated in the biopharma and life sciences sector, making it vulnerable to industry-specific fluctuations.
-
High Working Capital Needs: The business model requires significant working capital, which may affect liquidity and operational flexibility.
-
Rising Borrowings: The company’s borrowings increased sharply from Rs. 9.88 crore in FY24 to Rs. 54.62 crore in FY25, indicating higher financial leverage.
-
Earnings Dilution Post-Issue: The EPS is expected to decline from Rs. 14.34 pre-issue to Rs. 10.45 post-issue due to equity dilution, impacting shareholder value.
-
Regulatory Compliance Risk: As Fabtech operates globally, any non-compliance with international regulatory standards could disrupt business operations and affect growth.
FAQs
What are the IPO dates for Fabtech Technologies Ltd? +
What is the issue size of the Fabtech Technologies IPO? +
What is the price band and lot size? +
When is the allotment and listing date? +
Who are the promoters of Fabtech Technologies Ltd? +

Explore Other Products

Rupeezy AppAdvanced charts, advanced Option Chain, instant pay-in & pay-out,margin .Learn More
Rupeezy <> TradingViewEnjoy top-class trading experience enhanced by advanced TradingView charts.Learn More
DockPortfolio analysis, pledge holdings, apply in IPOs & download reports Learn More